THE BUSINESS OF BIOTECH

58:25 Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small
Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

On this week's Business Of Biotech episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-changing technology that turned the mountains blue on cold Coors Light beer cans, to launching a dye-drug conjuga...

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Roger Cone
Courage Therapeutics
PLAY

MEET YOUR HOST

Ben ComerBen Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.

Interested in joining us on air? Contact us